OBJECTIVES: The hyperintense acute reperfusion marker (HARM) has been described as a predictor for haemorrhagic transformation (HT) in acute ischaemic stroke. We hypothesised that this phenomenon is not present in the elderly. METHODS: It was possible to assess 47/84 consecutive patients aged 80 and over with diagnosed ischaemic stroke or transient ischaemic attack (TIA). MRI was performed within 24 h of onset of symptoms with follow-up MRI within a further 48 h. RESULTS: Of 47 included patients, 19 showed HARM; it was only seen on follow-up examination. Ten of the 47 patients underwent thrombolysis with recombinant tissue plasminogen activator (rt-PA); 4 of them showed HARM, and 1 of those showed HT. HARM was found in three out of eight patients with haemorrhagic transformation on baseline and/or follow-up MRI. We did not observe an association between HARM and early HT either in the whole group or in the patients who received thrombolysis. CONCLUSION: HARM was not associated with HT in the elderly after ischaemic stroke, independent of treatment. While it may indicate dysfunction of the blood-brain barrier (BBB), it does not necessarily amount to HT.
OBJECTIVES: The hyperintense acute reperfusion marker (HARM) has been described as a predictor for haemorrhagic transformation (HT) in acute ischaemic stroke. We hypothesised that this phenomenon is not present in the elderly. METHODS: It was possible to assess 47/84 consecutive patients aged 80 and over with diagnosed ischaemic stroke or transient ischaemic attack (TIA). MRI was performed within 24 h of onset of symptoms with follow-up MRI within a further 48 h. RESULTS: Of 47 included patients, 19 showed HARM; it was only seen on follow-up examination. Ten of the 47 patients underwent thrombolysis with recombinant tissue plasminogen activator (rt-PA); 4 of them showed HARM, and 1 of those showed HT. HARM was found in three out of eight patients with haemorrhagic transformation on baseline and/or follow-up MRI. We did not observe an association between HARM and early HT either in the whole group or in the patients who received thrombolysis. CONCLUSION: HARM was not associated with HT in the elderly after ischaemic stroke, independent of treatment. While it may indicate dysfunction of the blood-brain barrier (BBB), it does not necessarily amount to HT.
Authors: Darren B Orbach; Chris Wu; Meng Law; James S Babb; Ray Lee; Abraham Padua; Edmond A Knopp Journal: J Magn Reson Imaging Date: 2006-07 Impact factor: 4.813
Authors: Eung Yeop Kim; Dong Gyu Na; Sam Soo Kim; Kwang Ho Lee; Jae Wook Ryoo; Ho Kyun Kim Journal: AJNR Am J Neuroradiol Date: 2005-05 Impact factor: 3.825
Authors: Lawrence L Latour; Dong-Wha Kang; Mustapha A Ezzeddine; Julio A Chalela; Steven Warach Journal: Ann Neurol Date: 2004-10 Impact factor: 10.422
Authors: Maarten G Lansberg; Vincent N Thijs; Roland Bammer; Stephanie Kemp; Christine A C Wijman; Michael P Marks; Gregory W Albers Journal: Stroke Date: 2007-06-14 Impact factor: 7.914
Authors: Mark Jrj Bouts; Ivo Acw Tiebosch; Umesh S Rudrapatna; Annette van der Toorn; Ona Wu; Rick M Dijkhuizen Journal: J Cereb Blood Flow Metab Date: 2016-01-01 Impact factor: 6.200
Authors: Anke Wouters; Lauranne Scheldeman; Patrick Dupont; Bastian Cheng; Martin Ebinger; Märit Jensen; Matthias Endres; Christian Gerloff; Keith W Muir; Norbert Nighoghossian; Salvador Pedraza; Claus Z Simonsen; Florent Boutitie; Vincent Thijs; Götz Thomalla; Jochen Fiebach; Robin Lemmens Journal: Eur Stroke J Date: 2021-06-12
Authors: Zurab Nadareishvili; Marie Luby; Richard Leigh; Jignesh Shah; John K Lynch; Amie W Hsia; Richard T Benson; Lawrence L Latour Journal: J Neuroimaging Date: 2017-07-19 Impact factor: 2.486
Authors: J G Merino; L L Latour; A Tso; K Y Lee; D W Kang; L A Davis; R M Lazar; K A Horvath; P J Corso; S Warach Journal: AJNR Am J Neuroradiol Date: 2012-08-23 Impact factor: 3.825